Organogenesis Holdings Inc (Organogenesis Holdings Inc (ORGO) is higher by Monday morning, with the stock increasing 8.14% in pre-market trading to 24.18.
ORGO's short-term technical score of 89 indicates that the stock has traded more bullishly over the last month than 89% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 142 out of 146 industries, Organogenesis Holdings Inc ranks higher than 98% of stocks.
Organogenesis Holdings Inc has risen 12.76% over the past month, closing at $19.96 on April 5. During this period of time, the stock fell as low as $19.96 and as high as $24.34. ORGO has an average analyst recommendation of Strong Buy. The company has an average price target of $26.00.
Organogenesis Holdings Inc has a Long-Term Technical rank of 98. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 2% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 136 by this metric, ORGO ranks better than 98% of stocks.
Important Dates for Investors in ORGO:
-Organogenesis Holdings Inc is set to release earnings on 5/10/2021. During their last earnings release the company posted EPS of $0.15. -We do not have a set dividend date for Organogenesis Holdings Inc at this time. Click Here to get the full Stock Score Report on Organogenesis Holdings Inc (ORGO) Stock.
